Wendell David Associates Inc. raised its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 32.7% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 1,482 shares of the semiconductor company’s stock after acquiring an additional 365 shares during the quarter. Wendell David Associates Inc.’s holdings in Synopsys were worth $760,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of SNPS. Nuveen LLC purchased a new stake in shares of Synopsys in the 1st quarter valued at about $341,480,000. Pictet Asset Management Holding SA raised its holdings in shares of Synopsys by 38.3% during the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock valued at $1,043,518,000 after buying an additional 673,837 shares in the last quarter. Generation Investment Management LLP purchased a new position in shares of Synopsys during the 1st quarter valued at about $240,491,000. Vanguard Group Inc. raised its holdings in shares of Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after buying an additional 346,994 shares in the last quarter. Finally, Alliancebernstein L.P. raised its holdings in shares of Synopsys by 22.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after buying an additional 313,218 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of SNPS stock opened at $447.64 on Friday. The firm has a market cap of $83.15 billion, a P/E ratio of 35.14, a P/E/G ratio of 4.93 and a beta of 1.10. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The business’s 50 day moving average price is $525.72 and its 200-day moving average price is $510.73. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62.
Insiders Place Their Bets
In other news, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the sale, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. This trade represents a 13.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 30,894 shares of company stock valued at $16,760,783 in the last 90 days. 0.62% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
SNPS has been the topic of a number of research reports. Needham & Company LLC decreased their price objective on Synopsys from $660.00 to $550.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Wall Street Zen cut Synopsys from a “hold” rating to a “sell” rating in a report on Saturday, September 13th. Rosenblatt Securities reissued a “neutral” rating and set a $605.00 price objective (down from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. JPMorgan Chase & Co. decreased their price objective on Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Finally, Bank of America restated an “underperform” rating and set a $525.00 price target (down from $625.00) on shares of Synopsys in a research report on Wednesday, September 10th. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $569.67.
View Our Latest Analysis on SNPS
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- The 3 Best Retail Stocks to Shop for in August
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- Ride Out The Recession With These Dividend Kings
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.